THMO — Thermogenesis Holdings Income Statement
0.000.00%
- $0.00m
- $0.97m
- $9.45m
- 22
- 84
- 21
- 38
Annual income statement for Thermogenesis Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 13 | 9.74 | 9.29 | 10.5 | 9.45 |
Cost of Revenue | |||||
Gross Profit | 5.7 | 1.26 | 3.49 | 2.71 | 1.93 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 18.6 | 18.6 | 15.9 | 16.7 | 18.4 |
Operating Profit | -5.57 | -8.89 | -6.58 | -6.19 | -8.94 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.1 | -16.8 | -11.9 | -11.8 | -18.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.1 | -16.8 | -11.9 | -11.8 | -18.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -9.5 | -16.4 | -11.4 | -11.3 | -18 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -9.5 | -16.4 | -11.4 | -11.3 | -18 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -138 | -117 | -45.9 | -20.5 | -6.59 |